Michael A. Jenike - McLean Hospital - Harvard University
Michael A. Jenike - McLean Hospital - Harvard University
Michael A. Jenike - McLean Hospital - Harvard University
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
53<br />
4. Sertraline OCD Study Group (Chouinard G, Goodman W, Greist J, <strong>Jenike</strong> M,<br />
Rasmussen S, White K). Multicenter placebo controlled study of sertraline in<br />
obsessive-compulsive disorder. American Academy of Neuropharmacology<br />
(ACNP) Annual Meeting. Hawaii. October 1989.<br />
5. Sertraline OCD Study Group (Chouinard G, Goodman W, Greist J, <strong>Jenike</strong> M,<br />
Rasmussen S, White K). Multicenter placebo controlled study of sertraline in<br />
obsessive-compulsive disorder. World Psychiatric Association Meetings.<br />
Athens, Greece. October 1989.<br />
6. Chouinard G, Goodman W, Greist J, <strong>Jenike</strong> M, Rasmussen S, White K, Hackett<br />
E, Gaffney M, Bick P. Obsessive-compulsive disorder - Treatment with<br />
sertraline: A multicenter study. American Psychiatric Association Annual<br />
Meeting. New York. May 1990.<br />
7. DeVeaugh-Geiss JA, Landau PR, Katz RL, <strong>Jenike</strong> MA, et al. Clomipramine<br />
hydrochloride in the treatment of patients with obsessive-compulsive disorder.<br />
American Psychiatric Association Annual Meeting. New York. May 1990.<br />
8. Baer L, <strong>Jenike</strong> MA. Comorbid personality disorders and traits in obsessive<br />
compulsive disorder. American Psychiatric Association Annual Meeting. New<br />
York. May 1990.<br />
9. <strong>Jenike</strong> MA. Psychopharmacological and psychosurgical treatments of obsessive<br />
compulsive disorder. American Psychiatric Association Annual Meeting. New<br />
York. May 1990.<br />
10. <strong>Jenike</strong> MA. Oral physostigmine treatment for patients with presenile and senile<br />
dementia of Alzheimer's type. Parkinson/Alzheimer Digest 5:29, 1990.<br />
11. <strong>Jenike</strong> MA, Hyman SE, Baer L, Buttolph L, Summergrad P, Minichiello WE,<br />
Holland A, Seymour R, Ricciardi J. A controlled trial of fluvoxamine for<br />
obsessive-compulsive disorder: Implications for a serotonergic theory. Clinical<br />
Digest Series. Northbrook, Il. (in press).<br />
12. Alpert NM, Rauch SL, Kosslyn SM, Caplan D, Stromswold P, Holtzman P,<br />
Matthysse S, <strong>Jenike</strong> MA, Baer L, O'Driscoll G, Breiter HCR, Fischman AJ:<br />
Application of PET activation paradigms in neuroscience. MGH Research<br />
Abstracts. 1/93.<br />
13. <strong>Jenike</strong> MA, Goodman W, Greist JH, Kozak M, Lieberman JA, Liebowitz M,<br />
Rasmussen SA, White K. Fluvoxamine in the treatment of obsessive-compulsive<br />
disorder: Time-course and prediction of outcome. Anxiety Disorders Association,<br />
12th Annual Conference, March 19, 1993. Charleston, South Carolina.
Change language